the aid library

Ministry of Health and Social Services (MOHSS) , PEPFAR, Namibia Statistics Agency, Namibia Institute of Pathology Limited MHSS (2017) C2

The Namibia Population-based HIV Impact Assessment (NAMPHIA) 2017 | The Ministry of Health and Services is leading the NAMPHIA survey in collaboration with the Namibia Statistics Agency (NSA) and the Namibia Institute of Pathology (NIP). The survey is supported by the United States President’s Eme... more

Download (391)

View PDF (701)

NAMPHIA (Namibia Population-Based HIV Impact Assessment) Brochure

Ministry of Health and Social Services (MOHSS), PEPFAR, Namibia Statistics Agency, Namibia Institute of Pathology Limited MHSS (2017) C2

Download (193)

View PDF (213)

Zambia Population-based HIV Impact Assessement ZAMPHIA 2016

Ministry of Health, Zambia; Zambia National Public Health Institute; University of Zambia, et al. (2019) CC

External Link

Access to HIV care and treatment for migrants between Lesotho and South Africa: a mixed methods study

I. Faturiyele, D. Karletsos, K. Ntene-Sealiete, et al. BMC Public Health (2018) CC

BMC Public Health (2018) 18:668 https://doi.org/10.1186/s12889-018-5594-3

Download (119)

View PDF (146)

PEPFAR - U.S. President's Emergency Plan for AIDS Relief

United States of America - Department of State (2018) C2

2018 Progress Report PEPFAR Strategy for Accelerating HIV/AIDS Epidemic Control (2017-2020)

Download (144)

View PDF (177)

Ending Aids - Progress towards the 90-90-90 targets - Global Aids Update 2017

UNAIDS UNAIDS (2017) C2

Global AIDS Update 2017 Joint United Nations Programme on HIV/AIDS (UNAIDS)

Download (218)

View PDF (216)

Improving UNAIDS’ paediatric and adolescent estimates

UNAIDS (2019) C2

Accessed: 20.10.2019

Download (155)

View PDF (189)

Amélioration des estimations ONUSIDA relatives au VIH chez les enfants et les adolescents

ONUSIDA (2019) C2

Accessed: 02.11.2019

External Link

The global burden of chromoblastomycosis

Santos, D.; Pedrozo e Silva de Azevedo, C.; Aparecida Vincent, V. et al. (2021) CC

Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.

External Link

Chromoblastomycosis: a neglected tropical disease

Scientific Electronic Library Online SciELO (2015) CC

Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM... more

Download (634)

View PDF (808)

Consolidated guidelines on HIV testing services

World Health Organization WHO (2020) C_WHO

These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations. The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr... more

Download (732)

View PDF (1094)

Malawi AIDS Response Progress Report

Government of Malawi, Ministry of Health (2015) C1

Download (538)

View PDF (909)

FY 2015 Tanzania Country Operational Plan

PEPFAR (2016) C1

Download (683)

View PDF (1187)

Malawi Demographic and Health Survey 2015-2016
recommended

National Statistical Office Zomba, Malawi ; The DHS Program USAID; UNICEF; UNFPA; et al. (2017) C1

Download (482)

View PDF (1076)

Malawi Population-Based Impact Assessment (MPHIA 2016). Preliminary Findings

Ministry of Health, Malawi (2016) C1

External Link

Guidelines - European AIDS Clinical Society (EACS)

European AIDS Clinical Society (EACS) European AIDS Clinical Society (EACS) (2020) C2

Version 10.1_5 October 2020 These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website. The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ... more